Immune dysregulation and Th2 polarization are associated with atopic dermatitis in heart-transplant children: A delicate balance between risk of rejection or atopic symptoms.


Journal

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638

Informations de publication

Date de publication:
05 2019
Historique:
received: 20 08 2018
revised: 20 12 2018
accepted: 27 12 2018
pubmed: 8 1 2019
medline: 5 8 2020
entrez: 8 1 2019
Statut: ppublish

Résumé

Atopic dermatitis (AD) has a high incidence in heart-transplant children, and the reason why there is more AD after transplantation is still unknown. We conducted a cross-sectional study comparing 11 AD and 11 non-AD age-matched heart-transplant children, to assess which immune alterations are related to AD in these patients. AD patients had been transplanted at a younger age compared to non-AD, indicating that age at transplant may be determinant in the onset of AD. The earlier thymectomy in AD heart-transplant children favored the presence of more differentiated phenotypes in the T cell compartment. We observed a clear reduction in the T-helper 1/T-helper 2 (Th1/Th2) ratio in AD children. This Th2 polarization was related to eosinophilia and high immunoglobulin E levels, but also to an impaired regulatory T cell (Treg) suppression, which could be secondary to an exhaustion of the Treg compartment. Interestingly, AD patients were free of rejection episodes (0/11) in comparison to non-AD children (4/11). We propose that a predominant Th2 phenotype may prevent the emergence of Th1 responses associated with graft rejection. A more differentiated Treg phenotype could also play a role in preventing acute rejection in the first year posttransplant. Our findings provide useful insights and knowledge for the better understanding of atopic disorders in transplanted children.

Identifiants

pubmed: 30614192
doi: 10.1111/ajt.15245
pii: S1600-6135(22)09087-6
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1536-1544

Subventions

Organisme : Instituto de Salud Carlos III
ID : ICI14/00282
Pays : International
Organisme : Instituto de Salud Carlos III
ID : PI15/00011
Pays : International
Organisme : Instituto de Salud Carlos III
ID : PI15/00923
Pays : International
Organisme : Consejería de Educación, Juventud y Deporte, Comunidad de Madrid
ID : B2017/BMD-3727
Pays : International
Organisme : Fundación Familia Alonso
ID : FFA-2019
Pays : International

Informations de copyright

© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.

Auteurs

Jacobo López-Abente (J)

Laboratory of Immune-regulation, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.

Esther Bernaldo-de-Quirós (E)

Laboratory of Immune-regulation, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.

Manuela Camino (M)

Pediatric-Cardiology Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Nuria Gil (N)

Pediatric-Cardiology Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Esther Panadero (E)

Pediatric-Cardiology Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Minia Campos-Domínguez (M)

Laboratory of Immune-regulation, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Dermatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Elena Seoane-Reula (E)

Laboratory of Immune-regulation, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Pediatric Immunology Unit of the Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Juan M Gil-Jaurena (JM)

Pediatric Cardiac Surgery Unit of the Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Marjorie Pion (M)

Laboratory of Immune-regulation, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.

Rafael Correa-Rocha (R)

Laboratory of Immune-regulation, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Canadian National Transplant Research Program, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH